Agency Forms Undergoing Paperwork Reduction Act Review, 13345-13346 [2013-04510]
Download as PDF
13345
Federal Register / Vol. 78, No. 39 / Wednesday, February 27, 2013 / Notices
*Assumptions: One respondent per
hospital, collection of data on median of
75 patients per hospital, average data
collection time of 15 minutes per
patient.
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2013–04508 Filed 2–26–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–13–0263]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Requirements for the Importation of
Nonhuman Primates into the United
States (formerly Requirements for a
Special Permit to Import Cynomolgus,
African Green, or Rhesus Monkeys into
the United States) (OMB Control No.
0920–0263 Exp.6/30/2014)—Revision—
National Center Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Since May 1990, CDC has monitored
the arrival and/or uncrating of certain
shipments of non-human primates
imported into the United States under a
special permit program specific to
Cynomolgus, African Green, or Rhesus
Monkeys. CDC has monitored
compliance with this special permit
through the collection of information
focused on determining whether or not
importers conduct adequate disease
control practices. Importers were
required to renew their special permit
every 180 days.
In February 2013, CDC promulgated
two regulations pertaining to the
importation of nonhuman primates. The
first rule rule, Requirements for
Importers of Nonhuman Primates (2/15/
2013, Vol. 78, No. 32/p. 11522)
consolidates into 42 CFR 71.53 the
requirements previously found in 42
CFR part 71.53 with those found in the
Special Permit to Import Cynomolgus,
African Green, or Rhesus Monkeys into
the United States. It also extended the
time period for registration/permit
renewal from 180 days to 2 years. The
Special Permit has been withdrawn. The
requirements found therein are now
incorporated into the revised final rule
for 42 CFR 71.53. The second rule,
Establishment of User Fees for Filovirus
Testing of Nonhuman Primate Liver
Samples (2/12/2013, Vol.78, No. 29,
p.9828), outlines a process by which
importers can send liver tissues to CDC
from primates that die during
importation from reasons other than
trauma. CDC performs these tests due to
the absence of a private sector option.
CDC feels these regulatory changes
balance the public health risks posed by
the importation of nonhuman primates
with the burden imposed on regulating
their importation.
These rule changes have prompted
CDC to modify how it administers the
information collected from the public in
the enforcement of nonhuman primate
regulations. CDC is requesting the
following changes:
1. CDC requests that this information
collection request be re-named
‘‘Requirements for the Importation of
Nonhuman Primates into the United
States’’ to more accurately reflect the
type of information that is requested
from respondents.
2. To streamline administration of this
information collection request, CDC
requests that CDC form 75.10A
Application for Registration as an
Importer of Nonhuman Primates and the
Recordkeeping requirement currently
approved under OMB Control Number
0920–0134 Foreign Quarantine
Regulations, be moved and included in
this revision to OMB Control Number
0920–0263. This action places all
nonhuman primate information
collection requirements and requests
into one information collection request
administered by CDC.
3. CDC is renaming the different
portions of the information collected in
this information collection to more
accurately list the types of forms and
documentation CDC collects from
importers of nonhuman primates.
Therefore, the former information
categories of Businesses (limited
permit), Businesses (extended permit),
and Organizations (extended permit) are
being renamed and reorganized. The
information contained in these
categories will now be accounted for in
the Documentation sections of the
burden table. This categorization will
more accurately reflect CDC’s
interaction with the importers.
4. CDC also requests additional
burden hours to account for notification
to CDC from importers of shipment
arrivals and requests for release from
quarantine.
5. CDC further requests the addition
of the Filovirus Diagnostic Specimen
Submission Form for Non-human
Primate Materials, which will be used to
collect all of the necessary information
from nonhuman primate importers to
test nonhuman primate liver samples for
filovirus and communicate the results of
this test. This action adds
approximately 50 hours of burden to
this information collection request.
This information collection involves
minimal personally identifiable
information and should have limited
impact on an individual’s privacy.
There are no costs to respondents other
than their time.
The total burden requested for this
information collection is 146.
erowe on DSK2VPTVN1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Nonhuman Primate Importer ..........................
Nonhuman Primate Importer ..........................
VerDate Mar<15>2010
15:18 Feb 26, 2013
Jkt 229001
71.53(g)
New
Importer
Nonhuman Primates.
71.53(g)
Importer
ReNonhuman Primates.
PO 00000
Frm 00046
Fmt 4703
Number of
responses per
respondent
Number of
respondents
Form name/CFR reference
Average
burden per
response
(in hours)
Registration—
1
1
10/60
Registration—
12
1
10/60
Sfmt 4703
E:\FR\FM\27FEN1.SGM
27FEN1
13346
Federal Register / Vol. 78, No. 39 / Wednesday, February 27, 2013 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name/CFR reference
Nonhuman Primate Importer ..........................
71.53(h) Documentation (no form) (New Importer).
71.53(h) Documentation (no form) (Registered Importer).
Recordkeeping and reporting requirements
for importing NHPs: Notification of shipment arrival 71.53(n) (no form).
Quarantine release 71.53(l) (No form) ...........
71.53 (v) .........................................................
Form: Filovirus Diagnostic Specimen Submission Form for Non-human Primate Materials.
Nonhuman Primate Importer ..........................
Nonhuman Primate Importer ..........................
Nonhuman Primate Importer ..........................
Nonhuman Primate Importer ..........................
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2013–04510 Filed 2–26–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Medicare Program; Changes to the
Semi-Annual Meeting of the Advisory
Panel on Hospital Outpatient Payment
(HOP Panel)—March 11 and March 12,
2013
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting date and time,
location, and format change.
AGENCY:
SUMMARY: This notice announces
changes to the meeting date and time,
location, and format of the first semiannual public meeting of 2013 that was
announced and published in the
Federal Register on November 26, 2012,
entitled ‘‘Medicare Program; SemiAnnual Meeting of the Advisory Panel
on Hospital Outpatient Payment (HOP
Panel)—March 11 and 12, 2013.’’
DATES: Monday, March 11, 2013, from 1
p.m. to 5 p.m. Eastern Daylight Time
(EDT).
FOR FURTHER INFORMATION CONTACT:
erowe on DSK2VPTVN1PROD with NOTICES
Chuck Braver, (410) 786–3985.
SUPPLEMENTARY INFORMATION:
I. Background
On November 26, 2012, we published
a notice in the Federal Register (77 FR
70447) announcing the first semi-annual
meeting of the Advisory Panel on
VerDate Mar<15>2010
15:18 Feb 26, 2013
Jkt 229001
Hospital Outpatient Payment (HOP, the
Panel) for 2013. We note that the
November 26, 2012 notice provides
specific information on the purpose of
the meeting and the agenda. This
information remains the same and has
not changed with the exception of the
meeting date and time, location, and
format as specified in this notice. We
refer readers to that previously
published notice for general
information.
II. Provisions of the Notice
[CMS–1597–N2]
The November 26, 2012, notice
announced an in-person meeting to be
held over two days, March 11 through
12, 2013. Since the publication of that
notice, the date and time, location, and
format of the Panel meeting has
changed. Therefore, we are publishing
this notice to provide the public with
the necessary information related to this
upcoming public Panel meeting.
First, the November 26, 2012, notice
included the published date of the Panel
meeting as Monday, March 11, 2013,
from 1 p.m. to 5 p.m. EDT and Tuesday,
March 12, 2013, from 9 a.m. to 5 p.m.
EDT. The Panel meeting date and time
has been changed and will only take
place on March 11, 2013, from 1 p.m.
to 5 p.m. EDT.
Second, the November 26, 2012 notice
included, the published meeting
location as the CMS Central Office
Auditorium, 7500 Security Boulevard,
Woodlawn, Maryland 21244–1850. The
Panel meeting format has been changed
to Teleconference, Webcast, and
Webinar. Therefore, there will no longer
be an in-person meeting location for this
public Panel meeting. Participants
should view the CMS Web site at:
https://cms.hhs.gov/Regulations-andGuidance/Guidance/FACA/Advisory
PanelonAmbulatoryPayment
ClassificationGroups.html for the most
current details regarding the meeting.
PO 00000
Frm 00047
Fmt 4703
Sfmt 9990
Number of
responses per
respondent
Number of
respondents
Type of respondent
Average
burden per
response
(in hours)
1
1
10
12
1
30/60
25
6
15/60
25
10
6
15
15/60
20/60
Participants who have registered to
attend the in-person meeting based on
the November 26, 2012 notice do not
have to re-register. The teleconference
dial-in instructions, and related webcast
and webinar details will be posted on
the CMS Web site approximately 1 week
prior to the meeting at: https://
cms.hhs.gov/Regulations-andGuidance/Guidance/FACA/
AdvisoryPanelonAmbulatoryPayment
ClassificationGroups.html. Interested
participants who did not register will be
able to access the teleconference,
webcast, and webinar by following the
instructions on the above CMS Web site.
III. Collection of Information
Requirements
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
(Catalog of Federal Domestic Assistance
Program; No. 93.773 Medicare—Hospital
Insurance Program; and No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: February 20, 2012.
Marilyn Tavenner,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2013–04524 Filed 2–22–13; 4:15 pm]
BILLING CODE 4120–01–P
E:\FR\FM\27FEN1.SGM
27FEN1
Agencies
[Federal Register Volume 78, Number 39 (Wednesday, February 27, 2013)]
[Notices]
[Pages 13345-13346]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-04510]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-13-0263]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an email to
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this
notice.
Proposed Project
Requirements for the Importation of Nonhuman Primates into the
United States (formerly Requirements for a Special Permit to Import
Cynomolgus, African Green, or Rhesus Monkeys into the United States)
(OMB Control No. 0920-0263 Exp.6/30/2014)--Revision--National Center
Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Since May 1990, CDC has monitored the arrival and/or uncrating of
certain shipments of non-human primates imported into the United States
under a special permit program specific to Cynomolgus, African Green,
or Rhesus Monkeys. CDC has monitored compliance with this special
permit through the collection of information focused on determining
whether or not importers conduct adequate disease control practices.
Importers were required to renew their special permit every 180 days.
In February 2013, CDC promulgated two regulations pertaining to the
importation of nonhuman primates. The first rule rule, Requirements for
Importers of Nonhuman Primates (2/15/2013, Vol. 78, No. 32/p. 11522)
consolidates into 42 CFR 71.53 the requirements previously found in 42
CFR part 71.53 with those found in the Special Permit to Import
Cynomolgus, African Green, or Rhesus Monkeys into the United States. It
also extended the time period for registration/permit renewal from 180
days to 2 years. The Special Permit has been withdrawn. The
requirements found therein are now incorporated into the revised final
rule for 42 CFR 71.53. The second rule, Establishment of User Fees for
Filovirus Testing of Nonhuman Primate Liver Samples (2/12/2013, Vol.78,
No. 29, p.9828), outlines a process by which importers can send liver
tissues to CDC from primates that die during importation from reasons
other than trauma. CDC performs these tests due to the absence of a
private sector option. CDC feels these regulatory changes balance the
public health risks posed by the importation of nonhuman primates with
the burden imposed on regulating their importation.
These rule changes have prompted CDC to modify how it administers
the information collected from the public in the enforcement of
nonhuman primate regulations. CDC is requesting the following changes:
1. CDC requests that this information collection request be re-
named ``Requirements for the Importation of Nonhuman Primates into the
United States'' to more accurately reflect the type of information that
is requested from respondents.
2. To streamline administration of this information collection
request, CDC requests that CDC form 75.10A Application for Registration
as an Importer of Nonhuman Primates and the Recordkeeping requirement
currently approved under OMB Control Number 0920-0134 Foreign
Quarantine Regulations, be moved and included in this revision to OMB
Control Number 0920-0263. This action places all nonhuman primate
information collection requirements and requests into one information
collection request administered by CDC.
3. CDC is renaming the different portions of the information
collected in this information collection to more accurately list the
types of forms and documentation CDC collects from importers of
nonhuman primates. Therefore, the former information categories of
Businesses (limited permit), Businesses (extended permit), and
Organizations (extended permit) are being renamed and reorganized. The
information contained in these categories will now be accounted for in
the Documentation sections of the burden table. This categorization
will more accurately reflect CDC's interaction with the importers.
4. CDC also requests additional burden hours to account for
notification to CDC from importers of shipment arrivals and requests
for release from quarantine.
5. CDC further requests the addition of the Filovirus Diagnostic
Specimen Submission Form for Non-human Primate Materials, which will be
used to collect all of the necessary information from nonhuman primate
importers to test nonhuman primate liver samples for filovirus and
communicate the results of this test. This action adds approximately 50
hours of burden to this information collection request.
This information collection involves minimal personally
identifiable information and should have limited impact on an
individual's privacy. There are no costs to respondents other than
their time.
The total burden requested for this information collection is 146.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name/CFR reference respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Nonhuman Primate Importer............. 71.53(g) New Importer 1 1 10/60
Registration--Nonhuman
Primates.
Nonhuman Primate Importer............. 71.53(g) Importer Re- 12 1 10/60
Registration--Nonhuman
Primates.
[[Page 13346]]
Nonhuman Primate Importer............. 71.53(h) Documentation 1 1 10
(no form) (New
Importer).
Nonhuman Primate Importer............. 71.53(h) Documentation 12 1 30/60
(no form) (Registered
Importer).
Nonhuman Primate Importer............. Recordkeeping and 25 6 15/60
reporting requirements
for importing NHPs:
Notification of
shipment arrival
71.53(n) (no form).
Nonhuman Primate Importer............. Quarantine release 25 6 15/60
71.53(l) (No form).
Nonhuman Primate Importer............. 71.53 (v)............... 10 15 20/60
Form: Filovirus
Diagnostic Specimen
Submission Form for Non-
human Primate Materials.
----------------------------------------------------------------------------------------------------------------
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2013-04510 Filed 2-26-13; 8:45 am]
BILLING CODE 4163-18-P